Reaction Details |
| Report a problem with these data |
Target | TGF-beta receptor type-1 |
---|
Ligand | BDBM50151346 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_598612 (CHEMBL1048115) |
---|
IC50 | 20±n/a nM |
---|
Citation | Ren, JX; Li, LL; Zou, J; Yang, L; Yang, JL; Yang, SY Pharmacophore modeling and virtual screening for the discovery of new transforming growth factor-beta type I receptor (ALK5) inhibitors. Eur J Med Chem44:4259-65 (2009) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
TGF-beta receptor type-1 |
---|
Name: | TGF-beta receptor type-1 |
Synonyms: | ALK-5 | ALK5 | Activin A receptor type II-like protein kinase of 53kD | Activin receptor-like kinase 5 | SKR4 | Serine/threonine-protein kinase receptor R4 | TGF-beta receptor type I | TGF-beta type I receptor | TGFBR1 | TGFR-1 | TGFR1_HUMAN | TbetaR-I | Transforming growth factor-beta receptor type I |
Type: | enzyme |
Mol. Mass.: | 55968.24 |
Organism: | Homo sapiens (Human) |
Description: | P36897 |
Residue: | 503 |
Sequence: | MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTE
TTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPG
LGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDL
IYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER
SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE
GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS
ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI
HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA
ARLTALRIKKTLSQLSQQEGIKM
|
|
|
BDBM50151346 |
---|
n/a |
---|
Name | BDBM50151346 |
Synonyms: | 5-(1,5-naphthyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine | 5-[1,5]Naphthyridin-2-yl-4-pyridin-2-yl-thiazol-2-ylamine | CHEMBL181361 |
Type | Small organic molecule |
Emp. Form. | C16H11N5S |
Mol. Mass. | 305.357 |
SMILES | Nc1nc(c(s1)-c1ccc2ncccc2n1)-c1ccccn1 |
Structure |
|